Why the study?
Does an optimal Life's Simple 7 score reduce noncardiovascular disease events in adults aged 45-84 years?
Population
6,506 men and women aged between 45 and 84 years, enrolled in the Multi-Ethnic Study of Atherosclerosis.
Comparison
Optimal (11-14) Life's Simple 7 (LS7) score vs Inadequate (0-8) Life's Simple 7 (LS7) score
Design
Cohort
Follow-up
median 10.2 years
Authors
Loading...
May encourage LS7 optimization in practice; extends CV metrics to nonvascular outcomes but needs trial confirmation.
Does an optimal Life's Simple 7 score reduce noncardiovascular disease events in adults aged 45-84 years?
Improving cardiovascular health as measured by the Life's Simple 7 score is associated with a significantly reduced risk of multiple chronic nonvascular conditions, including cancer, chronic kidney disease, and COPD.
Ogunmoroti et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: